0
0.5
1
1.5
2+
Mortality
80%
Improvement
Relative Risk
Ventilation
31%
Discharge
-133%
primary
Hospitalization time
-50%
Enzalutamide Welén et al. LATE TREATMENT RCT
Is late treatment with antiandrogens beneficial for COVID-19?
RCT 39 patients in Sweden (July 2020 - May 2021)
Lower discharge (p=0.032) and longer hospitalization (p=0.01)
c19early.org
Welén et al., European Urology, December 2021
Favors enzalutamide
Favors control